Real World Evidence Conference

How Real World Evidence can be used for regulatory purposes

Back to Agenda

Networking Reception and DIA Exclusive

Session Chair(s)

Jacqueline A. Corrigan-Curay, JD, MD

Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER)

FDA, United States

Todd Phillips, PharmD, RAC

Director, Global Regulatory Affairs

Cardinal Health, United States

Alex Mutebi, PhD, MSc

Director, Real World Evidence

Vertex Pharmaceuticals, United States

Enjoy a complimentary evening of food, drinks, and networking with a multidisciplinary group of colleagues who share your passion to drive innovation from the lab to patients. Also, get an exclusive preview of the exciting content offerings via a fireside chat. RSVP Here: http://engage.diaglobal.org/DIA-2020-Exclusive-Cambridge.html

Have an account?